To gain further insight into the effects of Nrf2 in CD8+ T cells, we assessed the anti-tumor activity of antigen-specific CD8+ T cells using Nrf2-deficient or -overexpressing OT-I mice. Here, NFE2L2 is linked to neoplasm.